| Name | Title | Contact Details |
|---|
IMX Medical Management Services is a Bala Cynwyd, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 1924, Baptist Health has been bringing advanced medical technology, modern facilities, and many of the region`s most prominent physicians and medical professionals to the communities of our commonwealth for nearly a century. Headquartered in Louisville, the Baptist Health family of hospitals, care centers, physician offices and health facilities has experienced tremendous growth in recent years. Baptist Health Floyd in New Albany, Ind. (formerly known as Floyd Memorial Hospital and Health Services), is the newest member, joined on Oct. 1, 2016. In 2012, we welcomed Baptist Health Richmond (formerly Pattie A. Clay Regional Medical Center) and Baptist Health Madisonville (formerly Trover Health System) to the fold. Our other hospitals include Baptist Health Paducah, Baptist Health Louisville, Baptist Health La Grange, Baptist Health Lexington and Baptist Health Corbin. We also manage Hardin Memorial Health in Elizabethtown. Counting all nine hospitals, we have more than 2,700 licensed beds. Baptist Health`s 250+ outpatient facilities offer Urgent Care, Express Care, Occupational Medicine, Physical Therapy, Diagnostics and Home Care services. Our physician network of more than 3,000 employed and affiliated physicians continues to grow as we endeavor to improve access to healthcare and enhance the health of Kentucky as a whole.
Caring Senior Service San Antonio Texas is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Electro-Optical Sciences is a Irvington, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.